Brain Disease Modalities & Software Market by Product, Patient Type, Indication - Global Forecast 2025-2030- Product Image

Sale

Brain Disease Modalities & Software Market by Product, Patient Type, Indication - Global Forecast 2025-2030

Report
188 Pages
October 2024
Region: Global
360iResearch™
ID: 6011105

UP TO €678EUR$697USD£562GBP OFF until Dec 31^st 2024

The Brain Disease Modalities & Software Market grew from USD 15.18 billion in 2023 to USD 16.11 billion in 2024. It is expected to continue growing at a CAGR of 5.33%, reaching USD 21.84 billion by 2030.

The scope and definition of brain disease modalities and software encompass various tools and technologies designed to diagnose, treat, and manage neurological disorders such as Alzheimer's, Parkinson's, epilepsy, and multiple sclerosis. These solutions combine advancements in diagnostics, therapy, imaging, and data management. The necessity for these modalities arises from the increasing prevalence of neurological diseases due to aging populations and improved awareness and diagnosis rates of cognitive health issues. Applications span hospitals, research institutes, diagnostic centers, and home healthcare setups, where they aid in early detection, treatment optimization, and patient monitoring. Key growth factors include technological advancements like AI-driven imaging software, tele-neurology platforms, and increased R&D investments. Government initiatives and private sector funding further amplify market potential by driving innovation and infrastructure development.

However, market growth faces challenges such as high development costs, regulatory hurdles, and data privacy concerns, which can slow the adoption rates. Additionally, the complexity of brain diseases poses challenges in achieving accurate diagnostics and effective treatment solutions. Potential opportunities include harnessing big data analytics and machine learning to predict disease progression and develop personalized treatment strategies. Innovations can also focus on non-invasive imaging techniques and integrated software solutions that streamline workflows across multiple stakeholders in the healthcare system. Collaborations between tech companies and healthcare providers are crucial to bridge the existing gaps and foster user-centric solutions.

Moreover, the market demands continuous innovation in patient-centric software designed to improve quality of life and treatment adherence. Understanding patient demographics and disease patterns through enhanced data analytics can provide strategic insights, paving the way for targeted interventions. Companies focusing on developing comprehensive platforms that offer real-time monitoring and seamless integration with other e-health records are well-positioned to gain competitive advantages. Future growth will heavily rely on addressing the limitations through regulatory compliance, fostering cross-sector partnerships, and investing in emerging technologies that promise precision, efficiency, and accessibility in neurological healthcare solutions.

Understanding Market Dynamics in the Brain Disease Modalities & Software Market

The Brain Disease Modalities & Software Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Prevalence of brain disorders and increasing awareness regarding seeking diagnosis
- Government initiatives encouraging the use of digital solutions in brain disease management
- Increasing adoption of neuroimaging modalities for brain disease testing
Market Restraints
- Complexities of integrating software technologies in testing equipment
Market Opportunities
- Introduction of advanced brain disease software based on AI and ML
- Investments in the expansion and establishment of brain disease treatment centers
Market Challenges
- Concerns associated with data privacy and security breaches

Exploring Porter’s Five Forces for the Brain Disease Modalities & Software Market

Porter’s Five Forces framework further strengthens the insights of the Brain Disease Modalities & Software Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Brain Disease Modalities & Software Market

External macro-environmental factors deeply influence the performance of the Brain Disease Modalities & Software Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Brain Disease Modalities & Software Market

The Brain Disease Modalities & Software Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Brain Disease Modalities & Software Market

The Brain Disease Modalities & Software Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Brain Disease Modalities & Software Market

The Brain Disease Modalities & Software Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brain Disease Modalities & Software Market, highlighting leading vendors and their innovative profiles. These include Aspect Imaging Ltd., Brainomix Limited, Canon Medical Systems Corporation, Carestream Health, Inc., Esaote S.p.A., Fujifilm Holdings Corporation, General Electric Company,, Imaging Biometrics LLC, International Business Machines Corporation, IXICO plc., Koninklijke Philips N.V.,, MIM Software, Inc., Quantib B.V., ScienceSoft USA Corporation, Siemens Healthineers AG, and VUNO Inc..

Market Segmentation & Coverage

This research report categorizes the Brain Disease Modalities & Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Brain Analysis Software
- Brain Imaging Modalities
  - CT Devices
  - MRI Devices
  - PET Devices
  - PET-CT
  - PET-MRI
Patient Type
- Adults
- Infants
- Pediatrics
Indication
- Brain Diseases
  - Brain Cancer
  - Central Nervous System Cancer
  - Idiopathic Epilepsy
  - Ischemic Stroke
- Neurodegenerative Diseases
  - Alzheimer’s Disease
  - Motor Neuron Disease
  - Multiple Sclerosis
  - Parkinson’s Disease

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of brain disorders and increasing awareness regarding seeking diagnosis
5.1.1.2. Government initiatives encouraging the use of digital solutions in brain disease management
5.1.1.3. Increasing adoption of neuroimaging modalities for brain disease testing
5.1.2. Restraints
5.1.2.1. Complexities of integrating software technologies in testing equipment
5.1.3. Opportunities
5.1.3.1. Introduction of advanced brain disease software based on AI and ML
5.1.3.2. Investments in the expansion and establishment of brain disease treatment centers
5.1.4. Challenges
5.1.4.1. Concerns associated with data privacy and security breaches
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Brain Disease Modalities & Software Market, by Product

6.1. Introduction
6.2. Brain Analysis Software
6.3. Brain Imaging Modalities
6.3.1. CT Devices
6.3.2. MRI Devices
6.3.3. PET Devices
6.3.4. PET-CT
6.3.5. PET-MRI

7. Brain Disease Modalities & Software Market, by Patient Type

7.1. Introduction
7.2. Adults
7.3. Infants
7.4. Pediatrics

8. Brain Disease Modalities & Software Market, by Indication

8.1. Introduction
8.2. Brain Diseases
8.2.1. Brain Cancer
8.2.2. Central Nervous System Cancer
8.2.3. Idiopathic Epilepsy
8.2.4. Ischemic Stroke
8.3. Neurodegenerative Diseases
8.3.1. Alzheimer’s Disease
8.3.2. Motor Neuron Disease
8.3.3. Multiple Sclerosis
8.3.4. Parkinson’s Disease

9. Americas Brain Disease Modalities & Software Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Brain Disease Modalities & Software Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Brain Disease Modalities & Software Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

LIST OF FIGURES

FIGURE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET RESEARCH PROCESS
FIGURE 2. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. BRAIN DISEASE MODALITIES & SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BRAIN DISEASE MODALITIES & SOFTWARE MARKET DYNAMICS
TABLE 7. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MRI DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET-CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET-MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IDIOPATHIC EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ALZHEIMER’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MOTOR NEURON DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 52. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 54. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 57. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 58. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 60. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 63. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 84. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 86. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 89. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 90. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 92. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 93. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 95. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 102. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 104. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 105. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 107. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 138. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 140. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 143. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 157. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 159. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 160. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 162. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 163. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 165. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 166. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 167. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 168. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 169. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 171. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 172. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 173. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 174. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 175. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 177. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 178. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 180. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 181. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 183. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 184. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 186. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 193. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 195. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 196. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 197. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 198. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 211. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 213. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 214. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 215. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 216. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 217. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 219. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 220. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 221. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 222. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 223. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 225. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 226. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 227. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 228. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 247. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 249. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 250. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 251. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 252. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 265. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 266. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 267. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 268. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 269. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 270. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
TABLE 283. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. BRAIN DISEASE MODALITIES & SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Brain Disease Modalities & Software market, which are profiled in this report, include:

Aspect Imaging Ltd.
Brainomix Limited
Canon Medical Systems Corporation
Carestream Health, Inc.
Esaote S.p.A.
Fujifilm Holdings Corporation
General Electric Company,
Imaging Biometrics LLC
International Business Machines Corporation
IXICO plc.
Koninklijke Philips N.V.,
MIM Software, Inc.
Quantib B.V.
ScienceSoft USA Corporation
Siemens Healthineers AG
VUNO Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 16.11 Billion
Forecasted Market Value ( USD ) by 2030	$ 21.84 Billion
Compound Annual Growth Rate	5.3%
Regions Covered	Global
No. of Companies Mentioned	16

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3447EUR$3,545USD£2,857GBP €3830EUR$3,939USD£3,174GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6099EUR$6,272USD£5,054GBP €6777EUR$6,969USD£5,615GBP

Understanding Market Dynamics in the Brain Disease Modalities & Software Market

Exploring Porter’s Five Forces for the Brain Disease Modalities & Software Market

Applying PESTLE Analysis to the Brain Disease Modalities & Software Market

Analyzing Market Share in the Brain Disease Modalities & Software Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Brain Disease Modalities & Software Market

Strategic Recommendations for Success in the Brain Disease Modalities & Software Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Contract Life-cycle Management (CLM) Software - Global Strategic Business Report

Educational Software in the US - Industry Research Report

Lead Scoring Software Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Stroke Post Processing Software Market by Type, Installation, Modality, End-use - Global Forecast 2025-2030

Medical Image Analysis Software Market by Software, Image Type, Modality, Application, End-User - Global Forecast 2025-2030